arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

PepGen Inc.

PEPG
$2.33 ▼ -0.11 (-4.70%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
6 Visible periods
19 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

PepGen Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $98.4M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -63.5% ↗
FCF / Share $-1.94 ↗
Trailing P/E —
Price / Book 1.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

6-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-89.66M
— +0.4% —
FCF / Share Free cash flow per share
$-1.94
↑ +26.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
14
Cash Quality ↑
61

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 6 years · 23 quarters